Terumo BCT: North America
Sign In
CHANGE LOCATION
Asia Pacific
EMEA
Latin America
North America
This Site: Press Room
North America
Search
Home
About Terumo BCT
Our Markets
Products and Services
Support Center
Contact Us
Compliance
Corporate Responsibility
Executive Leadership
Events and Tradeshows
Press Room
Research
Blood Centers
Hospitals and Therapeutic Apheresis Centers
Biotech and Cell Processing
Trima Accel® Automated Blood Collection System
» Vista® Information System
» Cadence Data Collection System
» Outcome Review
Spectra Optia® Apheresis System
COBE® Spectra Apheresis System
COBE® 2991 Cell Processor
Elutra® Cell Separation System
Mirasol® Pathogen Reduction Technology
Atreus® Whole Blood Processing System
OrbiSac System
Quantum® Cell Expansion System
SCD® IIB
Integration Support
Knowledge Center
Education Events
» eSessions
» Successions
Training
» Operator
» Technical Service
Set/System Performance Reports
Warranty, Terms, Conditions
Product Certificates
Contact Support
Terumo BCT Careers
Our Culture
Total Rewards
Press Room
Compliance
Corporate Responsibility
Executive Leadership
Events and Tradeshows
Press Room
Research
Become a Member
As a member of CaridianBCT you have access to research materials through our online Knowledge Center.
Join Today
Press Room
2013 NEWS
16 APR, 2013 - U.S. FDA Clears Enhancement to Mononuclear Cell Collection Protocol for Spectra Optia® Apheresis System
9 APR, 2013 - FDA Clears the Terumo BCT Trima Accel® Automated Blood Collection System for the Collection and Storage of Platelets in PAS
20 MAR, 2013 - Terumo BCT Acquires Medservice
12 FEB, 2013 - Terumo BCT Announces First Patient Enrolled in North American Clinical Trial of Mirasol® Pathogen Reduction Technology System
8 JAN, 2013 - Terumo BCT to Bestow $100,000 Plasma Exchange Innovation Award
3 JAN, 2013 - Terumo BCT Receives FDA Approval to Conduct an Evaluation of its Polymorphonuclear Cell Collection Protocol
2012 NEWS
11 DEC, 2012 - Terumo BCT Launches New Clinical Trial: Red Blood Cell Exchange in Patients with Sickle Cell Disease Using the Spectra Optia® Apheresis System
9 OCT, 2012 - Terumo Medical Corp. Receives FDA Clearance for TSCD® II/Trucise® Data Management System
8 OCT, 2012 - Terumo BCT Launches $100,000 Grant with New Blood Safety Innovation Award
5 OCT, 2012 - Terumo BCT Receives U.S. FDA Clearance for PF24 and PF24RT24 for Apheresis Plasma Collected on the Trima Accel® Automated Blood Collection System
10 SEPT, 2012 - Terumo BCT Announces Winner of 2012 Plasma Exchange Innovation Award
10 JUL, 2012 - Terumo BCT Launches Mononuclear Cell Collection Protocol for Spectra Optia® Apheresis System in the United States
9 JUL, 2012 - Terumo BCT Awarded $3.5M Grant from the U.S. Department of Defense
18 MAY, 2012 - Terumo BCT Wins Governor’s Award for Excellence in Exporting
10 MAY, 2012 - Terumo BCT to Invest in State-of-the-Art Facilities in the U.S. and Vietnam
19 APR, 2012 - Terumo BCT Receives IDE Approval for Feasibility Study with the Mirasol® System
2 APR, 2012 - CaridianBCT and Terumo Transfusion Become Terumo BCT
21 MAR, 2012 - CaridianBCT Biotechnologies Research Highlights Published by DoD
1 MAR, 2012 - Terumo BCT Submits 510(k) for Mononuclear Cell (MNC) Collection on the Spectra Optia® Apheresis System
15 FEB, 2012 - David Perez to Testify before U.S. House Energy and Commerce Health Subcommittee
30 JAN, 2012 - Blood Systems Signs Agreement to Implement CaridianBCT Vista Information System
25 JAN, 2012 - CaridianBCT and Terumo Transfusion to Bestow $100,000 with New Plasma Exchange Innovation Award
2011 NEWS
24 OCT, 2011 - President and CEO of CaridianBCT and Terumo Transfusion Elected Chairman of the National Blood Foundation
22 OCT, 2011 - CaridianBCT and Terumo Transfusion Unveil New Milestones in Progress Toward Becoming Terumo BCT at AABB Annual Meeting & CTTXPO 2011
31 AUG, 2011 - CaridianBCT Launches Mononuclear Cell Collection Protocol for Spectra Optia® Apheresis System in Canada
26 May, 2011 - David Perez Appointed Chairman of the Global Blood Management Business Within Terumo Corporation
24 MAY, 2011 - Group Services for America's Blood Centers Honors CaridianBCT
14 APR, 2011 - Terumo Corporation Completes Acquisition of CaridianBCT
31 MAR, 2011 - CaridianBCT Revolutionizes Cell Therapy Industry with New Cell Expansion Product
7 MAR, 2011 -Terumo Corporation enters into agreement to acquire CaridianBCT
2010 News
18 NOV, 2010 - CaridianBCT Collaborates with CASCADE Consortium
28 SEP, 2010 - CaridianBCT Brings Solar Power to its Lakewood Facilities
17 AUG, 2010 - CaridianBCT Launches Latest Version of Trima Accel® Automated Blood Collection System
27 JUL, 2010 - Latest Release of Spectra Optia Apheresis System Now Available
27 JUL, 2010 - CaridianBCT Selected to Present Clinical Trial Results on Pathogen Reduction Technology
20 JUL, 2010 - Belgian Red Cross-Flanders Selects CaridianBCT’s Mirasol® Pathogen Reduction Technology System
23 JUN, 2010 - CaridianBCT’s Mirasol® Pathogen Reduction Technologies System Selected to Increase Safety of Poland’s Blood Supply
16 JUN, 2010 - Beckman Coulter to Distribute CaridianBCT Cell Therapy Products
16 JUN, 2010 - The Japanese Red Cross Considers CaridianBCT’s Mirasol
15 JUN, 2010 - CaridianBCT’s OrbiSac System Performs One Millionth Run
18 MAY, 2010 - CaridianBCT Releases Red Blood Cell Exchange Protocol in Canada
31 MAR, 2010 - External Experts Agree CaridianBCT’s Pathogen Reduction Technology Offers Effective Alternative to Gamma Irradiation for Preventing Transfusion-Associated Graft vs. Host Disease
3 MAR, 2010 - CaridianBCT Receives 510(k) Clearance on Latest Version of Trima Accel Automated Blood Collection System
2009 News
10 NOV, 2009 - CaridianBCT Launches Red Blood Cell Exchange Protocol
9 SEPT, 2009 - CaridianBCT Receives Grant Funding from US Department of Defense
6 AUG, 2009 - CaridianBCT Monitoring H1N1 Influenza Virus
23 JUN, 2009 - Certificates of Compliance for CaridianBCT Disposable Products Available
21 APR, 2009 - Héma-Québec Selects CaridianBCT for Automation and Informatics
14 APR, 2009 - CaridianBCT Introduces Automated Platelet Production in Europe
31 MAR, 2009 - US Department of Defense Names CaridianBCT in Global Medical Research Competition
24 MAR, 2009 - Jefferson Economic Council Honors CaridianBCT with Pioneer Award
12 JAN, 2009 - BCT Japan K.K. Soon to Become CaridianBCT K.K.
6 JAN, 2009 - CaridianBCT President and CEO to Speak at ACG Luncheon
2008 News
20 NOV, 2008 - CaridianBCT Launches Mononuclear Cell Collection Protocol
12 NOV, 2008 - CaridianBCT named 2008 Company of the Year by Colorado BioScience Association
10 OCT, 2008 - CaridianBCT Receives CE Mark for Mirasol® Pathogen Reduction Technology System
7 OCT, 2008 - CaridianBCT and American Red Cross Sign Strategic Agreement on Automated Blood Collection Technology
6 OCT, 2008 - Warsaw Blood Center selects CaridianBCT for Mirasol® Pathogen Reduction Technology
5 OCT, 2008 - CaridianBCT Initiates Clinical Trial for Whole Blood Process with Mirasol® Pathogen Reduction Technology
25 SEPT, 2008 - Blood Cell Storage and CaridianBCT sign option agreement
12 SEPT, 2008 - CaridianBCT Announces New Era of Automation and Informatics in the Blood Banking Industry
6 AUG, 2008 - CaridianBCT Receives CE Mark for Mirasol® Pathogen Reduction Technology System for Plasma
30 JUN, 2008 - FDA clears first automated whole blood processing system in U.S.
4 JUN, 2008 - Gambro BCT Soon To Become CaridianBCT
19 MAY, 2008 - CaridianBCT President and CEO David Perez Signs on as Corporate Chair For The Leukemia & Lymphoma Society’s Light The Night Walk
29 JAN, 2008 - Gambro BCT and Fenwal Suspend PASSPORT Post-Market Surveillance Study for 7-Day Platelets
Archived News
18 OCT, 2007 - Mirasol® Pathogen Reduction Technology System for Platelets Receives CE Mark
14 OCT, 2007 - Gambro BCT in the blood business
13 AUG, 2007 - FDA clears new medical device for use in therapeutic plasma exchange